Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis.
about
Genetic variation of occult hepatitis B virus infectionRole of occult hepatitis B virus infection in chronic hepatitis CManagement of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelinesMiR-122 in hepatitis B virus and hepatitis C virus dual infectionFactors influencing a low rate of hepatitis C viral RNA clearance in heroin users from Southern ChinaAn overview of triple infection with hepatitis B, C and D viruses.Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C.Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage studySerological and molecular expression of Hepatitis B infection in patients with chronic Hepatitis C from Tunisia, North Africa.Hepatitis B virus and hepatitis C virus dual infection.Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection.Epidemiological, clinical and histological characteristics of HBV/HDV co-infection: a retrospective cross-sectional study in Guangdong, ChinaLiver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progressionVirological and clinical characteristics of hepatitis delta virus in South Asia.Clinical Features and Seroepidemiology of Anti-HDV Antibody in patients With Chronic Hepatitis B Virus Infection in Iran: A Meta-Analysis.Impact of comorbidities on the severity of chronic hepatitis B at presentationBurden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India.Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection.Introduction to chronic hepatitis B infection.Lamivudine treatment in patients with chronic hepatitis B and cirrhosis.The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use.Telbivudine: a new option for the treatment of chronic hepatitis B.Prevalence of occult hepatitis B virus in plasma and peripheral blood mononuclear cell compartments of patients with chronic hepatitis C infection in tehran-iranCharacteristics of hepatitis B infection in a sample of omani patients.Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients with unusual clinical picturesCurrent therapy for hepatitis C or D or immunodeficiency virus concurrent infection with chronic hepatitis B.MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirinManagement of patients co-infected with HBV and HCV.Dual Infection with Hepatitis B and Epstein-Barr Virus Presenting with Severe Jaundice, Coagulopathy, and Hepatitis B Virus Chronicity Outcome.Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection.Circulating levels of collagen III and MMP-1 in patients with chronic hepatitis C co-infected with hepatitis B virus.Interference of replication between hepatitis B and C viruses in patients infected with HIV.Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-Treatment Patients With Chronic Hepatitis C: An Open-Label Control Study in China.TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism.Prevalence, incidence, and clinical relevance of the reverse transcriptase V207I mutation outside the YMDD motif of the hepatitis B virus polymerase during lamivudine therapy.Characterization of overt and occult hepatitis B virus infection among HTLV-1 positive healthy carriers in the Northeast of Iran; AN HTLV-I endemic area.Hepatic decompensation in patients with HIV/Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) triple infection versus HIV/HCV coinfection and the effect of anti-HBV nucleos(t)ide therapy.Past and current hepatitis E virus infection in renal transplant patients.Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection.
P2860
Q26751031-D9966060-2972-4447-A836-45714356FCC9Q26823538-4CC84D20-DC19-4A67-9689-4B035704EADAQ27000080-9B96DF36-2D5B-4626-9976-3DC011A64239Q27008894-BC8F797E-612B-45A3-97D3-35F67E4F68A4Q27488825-EF4B4CFD-AEAE-4BC3-A53B-449380FD93B3Q30485092-580422CB-2DFD-4F39-B5AF-BFE2EB6CBA6EQ33373813-C6D59DE1-93D2-48A6-A8D5-B1FAA39ACB7DQ33801743-D1BDE30C-4432-481C-9C6F-6AB120908547Q34174479-3F59047F-2ED7-4F78-B6A8-FE5BA15A1C5EQ34404975-6D48C313-4034-4803-9494-10522763C1F7Q34485074-3F6EF69F-DEFF-4506-B61D-21447C424C5CQ34757956-4B07208D-5C99-4680-AA63-84F306944E37Q34811974-90B11A75-C341-47BA-87AA-7895BAE04840Q35111441-CE863DF9-E2A5-45F6-A8A9-33AB9162A2BBQ35764198-7CD3F8B7-FEA6-46C6-9903-F9D223A22823Q35886670-82A5D77F-A1D0-492D-901C-DF467AC1743DQ35904838-4FF40237-9494-40D4-90B9-890FD729DBA8Q36318583-558861AE-6E1E-43E8-A369-6D93A8580CABQ36382631-666E0A71-9FC4-4C49-8C2D-F5106292E31DQ36573919-CD377041-F140-4F6B-B005-81F477D087B8Q36575228-6392123C-E24E-4D2A-B010-0269B20AC84CQ36810314-3AC1AE6C-123E-4517-A202-E4155B66E613Q37090963-B6A96D77-C2A5-4C63-9142-715E8D5FBA21Q37109576-BE7D98E5-2EDB-4C9B-9D72-F2D4A9B62BF8Q37132382-4A730389-6336-4399-9231-28587C0788BCQ37208961-432AFB8E-CD4A-4DA2-8A16-BB8F148A9430Q37278249-CA9F6E7E-2B9B-43E6-B5F0-1688A84E13FEQ37281927-415107C1-A0F9-4D42-940B-31235EC2ECCAQ37503341-8DDEACA1-CDA4-4CAC-825D-E0D9F56159B6Q37661862-5648696F-2A6A-45CE-BCC0-CA0DD3082F4FQ37855732-AF8D855D-E833-4F18-9A84-C0439DCA6697Q38861268-18E424A6-CA49-44BD-B2D5-BCC1337F034AQ39543611-3EFC1C17-F7EF-4B3D-AA37-AEBE26158F4EQ40062700-3378D125-9419-43B5-81DA-9BBF14B9B085Q41549262-4F657246-983D-45F2-8AF6-B35475ADA2C6Q41844014-889A8DE7-B919-44F5-B87F-106AB8EE6E14Q42199389-2BF7C1B1-5252-4CA5-B983-76A0BDDA0495Q42211468-173FBB11-7FC3-48EB-86AE-CC047FC4F501Q42232143-C8A3842D-654A-4928-BE9B-7179AF5F2F73Q42245958-00DA8EED-32C3-406E-B6E3-008592305BE5
P2860
Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Virologic and clinical express ...... tients with chronic hepatitis.
@en
Virologic and clinical express ...... tients with chronic hepatitis.
@nl
type
label
Virologic and clinical express ...... tients with chronic hepatitis.
@en
Virologic and clinical express ...... tients with chronic hepatitis.
@nl
prefLabel
Virologic and clinical express ...... tients with chronic hepatitis.
@en
Virologic and clinical express ...... tients with chronic hepatitis.
@nl
P2093
P356
P1433
P1476
Virologic and clinical express ...... tients with chronic hepatitis.
@en
P2093
Filippini P
Piccinino F
Santantonio T
Scolastico C
Stroffolini T
P304
P356
10.1053/JHEP.2000.19288
P407
P577
2000-11-01T00:00:00Z